Edition:
India

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

3.42USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$3.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,561
52-wk High
$10.41
52-wk Low
$2.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -2.144
Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.12
P/E Low - Last 5 Yrs. -- 22.71 23.41
Beta -- 0.86 0.87
Price to Sales (TTM) 15.98 6.59 8.44
Price to Book (MRQ) 3.32 5.12 5.27
Price to Tangible Book (MRQ) 3.32 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.70
Payout Ratio(TTM) -- 42.19 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 5.43 13.46
Sales (TTM) vs TTM 1 Yr. Ago 4,341.80 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -104.48 45.66 47.72
EPS (TTM) vs TTM 1 Yr. Ago 81.78 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 18.10 2.87 2.98
LT Debt to Equity (MRQ) 15.50 8.86 11.32
Total Debt to Equity (MRQ) 15.50 12.87 16.01
Interest Coverage (TTM) -15.86 32.47 28.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.11 52.40
Gross Margin - 5 Yr. Avg. -- 49.67 50.39
EBITD Margin (TTM) -156.26 -- --
EBITD - 5 Yr. Avg -- 17.26 12.41
Operating Margin (TTM) -157.49 13.53 5.67
Operating Margin - 5 Yr. Avg. -- 13.69 8.00
Pre-Tax Margin (TTM) -160.59 11.88 4.69
Pre-Tax Margin - 5 Yr. Avg. -- 14.09 8.28
Net Profit Margin (TTM) -160.59 8.79 1.42
Net Profit Margin - 5 Yr. Avg. -- 10.58 4.69
Effective Tax Rate (TTM) -- 22.13 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,433,188 820,080,499
Net Income/Employee (TTM) -- 105,143,011 92,828,553
Receivable Turnover (TTM) 89.37 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) 0.19 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 10.98 10.65
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -31.58 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -37.22 15.46 15.24
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 92.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.86%
# of Holders: 3
Total Shares Held: 2,981,300
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.